Fluid Imaging Technologies (Scarborough, ME), and the University of Colorado Boulder (Boulder, CO) have entered into an exclusive agreement to conduct primary laboratory research aimed at determining whether the university’s artificial intelligence (AI) software can detect bloodborne bacteria and identify the species from images collected using the company’s FlowCam Nano particle imaging and analysis system. Read more
Study to investigate use of artificial intelligence for identifying bloodborne bacteria
Related Posts
On the Record: Startup aims to turn scientific researchers into ‘deep-tech’ entrepreneurs
Justin Hafner, founder and former CEO of digital health startup Kinotek, aims to make an even bigger splash in the startup world...
Skincare startup funds UMaine scholarship to spark innovation
Marin Skincare, known for its Lobster Lotion product, partnered with the University of Maine to create a scholarship to spur innovation and...
Bigelow Lab looks to create ‘blue’ biotechnology businesses and jobs
Bigelow Laboratory for Ocean Sciences, an East Boothbay nonprofit research institute focused on global ocean health, last week launched a program...